Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

May 08, 2025

SELL
$16.07 - $31.84 $165,987 - $328,875
-10,329 Closed
0 $0
Q4 2023

May 08, 2025

BUY
$21.58 - $29.5 $4,035 - $5,516
187 Added 1.84%
10,329 $279 Million
Q3 2023

May 08, 2025

BUY
$25.8 - $39.97 $261,663 - $405,375
10,142 New
10,142 $301 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.5B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Pacific Capital Partners LTD Portfolio

Follow Pacific Capital Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Capital Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Capital Partners LTD with notifications on news.